Stathmin is over expressed in metastatic prostate cancer: Implications in prostate cancer progression

被引：0
|
作者：
Mehra, R [1 ]
Poisson, L [1 ]
Varambally, S [1 ]
Tomlins, S [1 ]
Kunju, L [1 ]
Ghosh, D [1 ]
Chinnaiyan, A [1 ]
Shah, RB [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
689
引用
收藏
页码：149A / 150A
页数：2
相关论文
共 50 条
  • [31] CXXC5 expression in prostate cancer: implications for cancer progression
    Benedetti, Ines
    De Marzo, Angelo M.
    Geliebter, Jan
    Reyes, Niradiz
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2017, 98 (04) : 234 - 243
  • [32] Implications of estrogens and their receptors for the development and progression of prostate cancer
    Bonkhoff, H
    Fixemer, T
    PATHOLOGE, 2005, 26 (06): : 461 - 468
  • [33] Prostatitis and prostate cancer: Implications for prostate cancer screening
    Kawakami, J
    Siemens, DR
    Nickel, JC
    UROLOGY, 2004, 64 (06) : 1075 - 1080
  • [34] PROSTATE CANCER The role of local therapy for metastatic prostate cancer
    Tosco, Lorenzo
    Van Poppel, Hendrik
    NATURE REVIEWS UROLOGY, 2014, 11 (03) : 134 - 135
  • [35] PROSTATE CANCER The best fit for enzalutamide in metastatic prostate cancer
    Pal, Sumanta K.
    Sartor, Oliver
    NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (09) : 504 - 506
  • [36] Bone and prostate cancer cell interactions in metastatic prostate cancer
    Vela, Ian
    Gregory, Laura
    Gardiner, Edith M.
    Clements, Judith A.
    Nicol, David L.
    BJU INTERNATIONAL, 2007, 99 (04) : 735 - 742
  • [37] PEMBROLIZUMAB MONOTHERAPY IS ACTIVE IN METASTATIC PROSTATE CANCER Prostate Cancer
    不详
    CANCER DISCOVERY, 2020, 10 (01) : 15 - 15
  • [38] SGEF is overexpressed in prostate cancer and contributes to prostate cancer progression
    Wang, Hongtao
    Wu, Ruiqin
    Yu, Lan
    Wu, Feima
    Li, Shanhu
    Zhao, Yali
    Li, Hailiang
    Luo, Guolan
    Wang, Jian
    Zhou, Jianguang
    ONCOLOGY REPORTS, 2012, 28 (04) : 1468 - 1474
  • [39] Pattern of progression and survival in hormonally treated metastatic prostate cancer
    Furuya, Y
    Akakura, K
    Akimoto, S
    Inomiya, H
    Ito, H
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (05) : 240 - 244
  • [40] Prognostic Factors Affecting Progression and Survival in Metastatic Prostate Cancer
    Nayyar, Rishi
    Sharma, Nitin
    Gupta, Narmada P.
    UROLOGIA INTERNATIONALIS, 2010, 84 (02) : 159 - 163
12345